Cancer Clinical Trials Results
Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT
||Main Campus|| || ||Blood & Marrow Transplant (BMT)
A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia and A Multi-Center, Phase III, Randomized Trial of Reduced Intensity Conditioning (RIC) and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow for Patients with Hematologic Malignancies
||Main Campus|| ||Phase 3||Blood & Marrow Transplant (BMT), Hematologic Malignancy
A Study of Low-dose Lenalidomide after Non-myeloablative Allogeneic Stem
||Main Campus|| || ||Blood & Marrow Transplant (BMT), Multiple Myeloma
A Study of Hematopoietic Stem Cell Supermobilization in Patients with Non-Hodgkin Lymphoma
||Main Campus|| || ||Blood & Marrow Transplant (BMT), Lymphoma, Lymphoma, Non - Hodgkin
(Adult/Pediatric) KIR Genotyping for Unrelated Donor (URD) Selection Prior to Hematopoietic Cell Transplantation (HCT) for AML: Selecting a Favorable KIR Donor
||Main Campus|| || ||Blood & Marrow Transplant (BMT), Leukemia, Acute Myeloid (AML)
(Adult/Pediatric) A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications
||Main Campus|| || ||Blood & Marrow Transplant (BMT), Hematologic Malignancy
(Pediatric) Defibrotide for patients with hepatic veno-occlusive disease (VOD): A treatment IND study (Under CFR 312.34)
||Main Campus||Stage 1|| ||Blood & Marrow Transplant (BMT), Hepatic Veno-Occlusive Disease (VOD)
Cancer Answers & Appointments
Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.
Monday through Friday from 8 a.m. – 4:30 p.m. (ET).
Resources for medical professionals
- Outpatient appointment referrals: 216.444.7923 or 866.223.8100
- Inpatient hospital transfers: 800.553.5056
- Referring Physician Concierge: 216.444.6196 or 216.312.4910.
Search available cancer clinical trials by disease, hospital, phase or number.
This information is provided by Cleveland Clinic and is not intended to replace
the medical advice of your doctor or health care provider.
Please consult your health care provider for advice about a specific medical condition.
© Copyright 2016 Cleveland Clinic. All rights reserved.